Paper Details

  1. Home
  2. Paper Details

Irritable bowel syndrome treatment using pinaverium bromide as a calcium channel blocker. A randomized double-blind placebo-controlled trial.

Author: AwadR, DibildoxM, OrtizF

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Irritable bowel syndrome is a major cause of missed work. As there is currently no effective treatment, sufferers often seek help from multiple doctors and try various medications over long periods. This has significant economic and social implications for families and workplaces.
Paper Details　
Original Abstract of the Article :
Irritable bowel syndrome is one of the principal causes of days lost from work. As there has been no effective treatment up to now, sufferers turn to various doctors and try all sorts of medicines over extended periods that last for years. Thus irritable bowel syndrome has become a serious socio-eco...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/8600700

データ提供：米国国立医学図書館（NLM）

Irritable Bowel Syndrome (IBS): Seeking Relief in the Desert of Digestive Distress

The desert of irritable bowel syndrome (IBS) can be a harsh and unforgiving place, marked by chronic digestive discomfort. This research seeks to find a path toward relief for those suffering from this debilitating condition. The researchers conducted a randomized, double-blind, placebo-controlled trial to assess the efficacy of pinaverium bromide, a calcium channel blocker, in treating IBS. Their goal is to discover a new and effective treatment option for this often-challenging condition.

A Potential Oasis in the Desert of Discomfort

The study suggests that pinaverium bromide may hold promise as a treatment for IBS. While further research is needed to confirm its effectiveness, this research offers a glimmer of hope for those seeking relief from the chronic discomfort of this condition.

A Brighter Future for IBS Sufferers

The results of this study encourage further exploration of pinaverium bromide as a potential treatment for IBS. This research could lead to the development of new and effective therapies for this condition, offering a brighter future for those who suffer from its debilitating symptoms.

Dr.Camel's Conclusion

Irritable bowel syndrome can feel like a constant desert storm, but this research offers a potential oasis of relief. Pinaverium bromide holds promise as a new treatment option, potentially offering a way to manage the discomfort and improve the quality of life for those struggling with IBS. While further research is needed, this study provides a glimmer of hope in the quest for effective treatments for this challenging condition.

Date :
  1. Date Completed 1996-05-01
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

8600700

DOI: Digital Object Identifier

8600700

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.